Professor David Russell-Jones
Please see Web sites:
Lead clinician for all district Diabetes and specialist Diabetes services. Lead Clinician for Endocrinology services,including regional Pituitary GH service, Lead physician Thyroid MDT (Surrey & N Hampshire), Adrenal MDT, Neuroendocrine MDT. Acute General Physician with own GIM take
Principal supervisor for 10 MD students to date, Supervisor 2 clinical SPRs 1 Academic F2,
F1 and CMT
Head of Department for Diabetes& Endocrinology
Previous member Clinical reference group CRG for NHS England for Specialist Endocrinology
Previous member Clinical reference group CRG for NHS England for Specialist Diabetes
Head of the Clinical advisory board for diabetes for Surrey PCT Previous regional STC Chairman &
Programme Director Diabetes & Endocrinology
Head of Clinical Academic Group Diabetes University of Surrey and Surrey NHS Hospitals.
Trustee for Sir Jules Thorne Trust (prestigious medical charity), Trustee UK Diabetes Research
Foundation. Member of advisory boards for all UK insulin manufacturers Novo Nordisk, Eli Lilly, Sanofi Aventis, Astra Zenica,
Member of a series of seminars run by the Smith Institue held at number 11 Downing Street to discuss care of chronically ill patients
Previous (17 years) Chairman SE Coast Research Ethics Committee.
Currently Principle investigator for 1 international studies and 1 NIHR study on Covid-19.
Raised the money and built innovative clinical Diabetes & Endocrinology centre incorporating research unit “CEDAR” Centre designed by Sir Nicholas Grimshaw and given to NHS
Elected member the Association of Physicians of UK and Ireland and the Association of
Have been chief applicant or co-applicant for research grants totalling £750K in the
last 5 years.
The use of stable isotopes to understand human physiology and pathophysiology, I Perform detailed metabolic studies to understand peptide hormone action particularly Insulin, IGF-I and Growth hormone. I have a particular interest in Insulin analogues and the possibility of creating Hepatoselective insulins.
I have an academic interest in formulating safe working conditions for people with
diabetes in safety critical roles including flying. Our work on flying with
insulin treated diabetes showing safety has designated one of the most
important papers in 2020 for people with diabetes.
I review grant applications for Welcome foundation, MRC, Diabetes UK, Danish MRC, and review articles for Diabetes Care, Diabetic Medicine, Diabetologia,Clinical Endocrinology, Lancet. Have wriiten leader BMJ
of many large international trials including:
Growth Hormone regulatory submission trial Lilly
Detemir type 1 diabetes regulatory submission trial Novo Nordisk
“Lead 5” Liraglutide trial Novo Nordisk
“Duration 4” Bydureon regulatory submission trial Lilly
“Imagine” Peglispro insulin trial Lilly
GrowthHormone regulatory submission trial Sandoz
“Onset 1” Fiasp insulin type 1 diabetes regulatory submission trial
“Take Control” Toujeo insulin trial Sanofi
National PI for many other clinical trials.
speaker at International meetings in 4 Continents in 2001-2017 including DUK, EASD, ISPAD, ADA,
IDF, CODY, DUK, BES, Hungarian Diabetes association, Slovenian diabetes association, French diabetes association, UAE diabetes association. and many National and International Diabetes Associations including Association of Physicians of India 2013. Invited Lecturer EASD “Cancer and insulin” the the largest attended EASD symposium ever) Hot Topics invited lecturer Diabetes UK Liverpool 2014, Hot Topics lecture “ New Insulins” EASD Vienna 2014, asked to present Dual programme by EASD 2015 Stockholm, Invited to speak by ADA at symposium Treating the obese
type1. Oral scientific presentations at ADA, EASD, BES, AES.
References of published papers Pub Med:
Currently 167 papers, 38 in the last 5 years listed on Pub Med.
Please see link below:
I am a keen sailor having represented UK at International events.